Low/Intermediate PCa Video Chat, March 23, 2026

by | Apr 7, 2026 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa

Low/Intermediate PCa Video Chat, March 23, 2026

Low/Intermediate PCa Video Chat, March 23, 2026

AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: High Dose Rate (HDR) brachytherapy versus stereotactic body radiotherapy (SBRT). (bj)

Topics Discussed
Importance of getting a second opinion on bioposy results; clincal study comparison of High Dose Rate (HDR) brachytherapy versus stereotactic body radiotherapy (SBRT); necessity of getting a second opinion on bioposy results for a Gleason 3+3 diagnosis; efficacy of specific supplements and dietary changes in reducing future prostate cancer risk and managing PSA levels.

Chat

Stuart sent a chat · 7:41 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

Stuart sent a chat · 7:42 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

Steve in Malaysia sent a chat · 8:49 PM
Hi guys, can you add me? Have a few questions.

Bill Franklin sent a chat · 8:51 PM
We should have plenty of time Steve.

Steve in Malaysia sent a chat · 8:51 PM
Thanks

Bill Franklin sent a chat · 9:08 PM
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2845485

Bill Franklin sent a chat · 9:09 PM
I think this is the one you’re talking about?  Just published in JAMA in Feb, 2026.

Bill Franklin sent a chat · 9:10 PM
JAMA HDR vs SBRT study https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2845485

Bill Franklin sent a chat · 9:10 PM
Rick and I had the same one.

Albert sent a chat · 9:16 PM
Thanks guys

AnCan – Rick sent a chat · 9:27 PM
https://themarsh.org/soloartsheal   Greg Burns  this Wednesday at 7.30 pm PACIFIC

Terri Richards sent a chat · 9:29 PM
Thank You So much Rick, My mic was not working > Thank you for all that you all do !

Ron Jr sent a chat · 9:30 PM
I forgot to ask:  Should I get a 2nd opinion on my Biopsy diagnosis of my GL 3+3 lesion? (or feel lucky about it, and sit down and be grateful)  Additionally, are there proven supplements or dietary changes that can reduce my future Prostate Cancer risk & PSA test numbers?